Key result
Transcatheter aortic valve implantation indications have expanded to intermediate- and low-risk patients, increasing the eligibility of elderly but fit individuals with aortic stenosis.
Why the study?
Indications for TAVI have expanded to intermediate- and low-risk patients, while rising life expectancy has increased elderly but fit individuals with aortic stenosis eligible for TAVI.
An umbrella review discussing the expanding indications of TAVI in elderly but fit individuals with aortic stenosis.
Expands TAVI eligibility among fit elderly patients; leaves open optimal lifetime management strategies in low-risk groups.
The management of aortic stenosis has seen momentous changes thanks to the introduction of transcatheter aortic valve implantation (TAVI, i.e., transcatheter aortic valve replacement). Indications to TAVI have expanded progressively to intermediate-and low-risk patients, but trends in life expectancy have led to an increase of elderly but fit individuals with aortic stenosis eligible for TAVI.
No takes yet. Share an insight, caveat, or question.
Antonazzo et al. (2020) studied this question. Transcatheter aortic valve implantation indications have expanded to intermediate- and low-risk patients, increasing the eligibility of elderly but fit individuals with aortic stenosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: